PL1838665T3 - Pochodne mutiliny i ich zastosowanie jako farmaceutyków - Google Patents

Pochodne mutiliny i ich zastosowanie jako farmaceutyków

Info

Publication number
PL1838665T3
PL1838665T3 PL07700066T PL07700066T PL1838665T3 PL 1838665 T3 PL1838665 T3 PL 1838665T3 PL 07700066 T PL07700066 T PL 07700066T PL 07700066 T PL07700066 T PL 07700066T PL 1838665 T3 PL1838665 T3 PL 1838665T3
Authority
PL
Poland
Prior art keywords
mutilins
phenylsulfanyl
acetyl
alkyl
pharmaceutical
Prior art date
Application number
PL07700066T
Other languages
English (en)
Inventor
Klaus Thirring
Gerd Ascher
Susanne Paukner
Werner Heilmayer
Rodger Novak
Original Assignee
Nabriva Therapeutics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabriva Therapeutics Ag filed Critical Nabriva Therapeutics Ag
Publication of PL1838665T3 publication Critical patent/PL1838665T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/22Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/76Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C07C2603/82Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Furan Compounds (AREA)
PL07700066T 2006-01-16 2007-01-11 Pochodne mutiliny i ich zastosowanie jako farmaceutyków PL1838665T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06000827A EP1808431A1 (en) 2006-01-16 2006-01-16 Mutilin derivatives and their use as pharmaceutical
EP07700066A EP1838665B1 (en) 2006-01-16 2007-01-11 Mutilin derivatives and their use as pharmaceutical
PCT/AT2007/000009 WO2007079515A1 (en) 2006-01-16 2007-01-11 Mutilin derivatives and their use as pharmaceutical

Publications (1)

Publication Number Publication Date
PL1838665T3 true PL1838665T3 (pl) 2011-09-30

Family

ID=36127922

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07700066T PL1838665T3 (pl) 2006-01-16 2007-01-11 Pochodne mutiliny i ich zastosowanie jako farmaceutyków

Country Status (17)

Country Link
US (1) US7816389B2 (pl)
EP (3) EP1808431A1 (pl)
JP (2) JP5489467B2 (pl)
KR (1) KR101434683B1 (pl)
CN (1) CN101379027B (pl)
AT (1) ATE502917T1 (pl)
BR (1) BRPI0707117B8 (pl)
CA (1) CA2635950C (pl)
DE (1) DE602007013306D1 (pl)
DK (1) DK1838665T3 (pl)
EA (1) EA019579B1 (pl)
ES (1) ES2363806T3 (pl)
IL (1) IL192756A (pl)
NO (1) NO341298B1 (pl)
PL (1) PL1838665T3 (pl)
TW (1) TWI428316B (pl)
WO (1) WO2007079515A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1808431A1 (en) 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin derivatives and their use as pharmaceutical
EP2014640A1 (en) 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives
US9701628B2 (en) * 2014-01-22 2017-07-11 Nabriva Therapeutics Ag 12-epi pleuromutilins
CN104803911B (zh) * 2014-01-23 2018-01-05 中国科学院上海药物研究所 一类截短侧耳素化合物、其药物组合物、合成方法与用途
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN115197169B (zh) * 2018-11-02 2023-07-11 华南农业大学 一种以2-氨基苯巯醇为连接基团截短侧耳素衍生物制备方法和用途
ES3056228T3 (en) * 2020-04-17 2026-02-19 Ariva Med Gmbh Antiviral use of pleuromutilins
EP4135681B1 (en) * 2020-04-17 2025-06-25 Nabriva Therapeutics GMBH Antiviral use of pleuromutilins
CN111689914B (zh) * 2020-06-18 2021-09-24 华南农业大学 一种具有1,2,4-三唑席夫碱的截短侧耳素衍生物及制备与应用
US20240383846A1 (en) * 2021-04-14 2024-11-21 London Pharmaceuticals And Research Corporation Mercaptoacetophenone aminohydrazones, their salts and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979423A (en) * 1969-07-25 1976-09-07 Biochemie Gesellschaft M.B.H. 14-Desoxy-14-tosyloxyacetoxy-mutilin
CH560180A5 (en) * 1971-10-05 1975-03-27 Sandoz Ag Pleuromutilin derivs - with antibacterial activity
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
CY1353A (en) * 1979-01-12 1987-04-24 Sandoz Ag New pleuromutilin derivatives, their production and use
JPS5594359A (en) * 1979-01-12 1980-07-17 Sandoz Ag Novel pleuromutilin derivatives*their manufacture and use
JP3054875B2 (ja) * 1995-02-13 2000-06-19 株式会社小松製作所 プラズマトーチ
GB9817029D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
WO2000027790A1 (en) * 1998-11-11 2000-05-18 Smithkline Beecham P.L.C. Mutilin compounds
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
GB0017031D0 (en) 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
PE20020676A1 (es) * 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
ES2295657T3 (es) 2002-07-24 2008-04-16 Nabriva Therapeutics Forschungs Gmbh Derivados de pleuromutilina como antimicrobianos.
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
EP2298733B1 (en) 2005-06-27 2016-05-25 Nabriva Therapeutics AG Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
GB0515995D0 (en) 2005-08-03 2005-09-07 Sandoz Ag Organic compounds
EP1808431A1 (en) 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin derivatives and their use as pharmaceutical
EP1972618A1 (en) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes

Also Published As

Publication number Publication date
EP1808431A1 (en) 2007-07-18
EP1838665B1 (en) 2011-03-23
JP2013136583A (ja) 2013-07-11
ATE502917T1 (de) 2011-04-15
CA2635950C (en) 2016-08-30
KR20080104273A (ko) 2008-12-02
CN101379027B (zh) 2014-09-24
HK1125624A1 (en) 2009-08-14
TWI428316B (zh) 2014-03-01
JP5489467B2 (ja) 2014-05-14
CA2635950A1 (en) 2007-07-19
EA019579B1 (ru) 2014-04-30
US7816389B2 (en) 2010-10-19
EA200870171A1 (ru) 2009-02-27
IL192756A (en) 2015-10-29
BRPI0707117B8 (pt) 2021-05-25
BRPI0707117B1 (pt) 2020-08-04
IL192756A0 (en) 2009-02-11
DK1838665T3 (da) 2011-07-11
CN101379027A (zh) 2009-03-04
DE602007013306D1 (de) 2011-05-05
KR101434683B1 (ko) 2014-08-26
EP2266955B1 (en) 2017-07-26
WO2007079515A1 (en) 2007-07-19
NO341298B1 (no) 2017-10-02
BRPI0707117A2 (pt) 2011-04-19
US20080287442A1 (en) 2008-11-20
ES2363806T3 (es) 2011-08-17
EP2266955A1 (en) 2010-12-29
JP2009531278A (ja) 2009-09-03
NO20083409L (no) 2008-09-18
TW200736205A (en) 2007-10-01
EP1838665A1 (en) 2007-10-03

Similar Documents

Publication Publication Date Title
IL192756A0 (en) Mutilin derivatives and their use as pharmaceutical
MX2009011165A (es) Formulaciones farmaceuticas que contienen derivados del acido lipoico.
AU2010246102A8 (en) Pesticidal compositions
SV2008003088A (es) Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen
HUE043555T2 (hu) Tetrahidrokannabinol gyógyszer elõanyagai (prodrugjai), kompozíciók, amelyek tetrahidrokannabinol gyógyszer elõanyagait tartalmazzák, és eljárások, ezek alkalmazására
TW200800999A (en) Novel compounds
IL190227A0 (en) Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
ECSP099451A (es) Compuestos de urea policíclicos antibacterianos
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
UY29856A1 (es) Forma cristalina 8d del clorhidrato de la ivabradina, su procedimiento de preparación, y las composiciones farmaceuticas que la contienen
NO20082413L (no) Mikrobiocidal sammensetning
GB0514463D0 (en) Use of pinolenic acid
MX2007011048A (es) Composiciones estables de peroxido organico.
WO2007005471A3 (en) Stable organic peroxide compositions
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
MY148651A (en) Antitumoral compounds
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
AR057885A1 (es) Acido 1-(1-(2- etoxietil) - 1- etil-7-(4- metilpiridin -2- ilamino)- 1h pirazolo (4,3-d) pirimidin -5- il) piperidina -4- carboxilico y las sales del mismo. composiciones farmaceuticas.
IL205981A0 (en) 15,16-METHYLENE-17-HYDROXY-19-NOR-21-CARBOXYLIC ACID ã?-LACTONE DERIVATIVE , USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE
EP1888519A2 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
GB0620005D0 (en) Compounds
AU2020902344A0 (en) Tetrahydrocannabinol usage in Veterinary Medicine
AU2020902306A0 (en) Cannabigerol usage in Veterinary Medicine
UA34286U (en) Disinfectant